IL139064A0 - Intermittent claudication therapeutic drugs comprising pyrroloazepines - Google Patents

Intermittent claudication therapeutic drugs comprising pyrroloazepines

Info

Publication number
IL139064A0
IL139064A0 IL13906400A IL13906400A IL139064A0 IL 139064 A0 IL139064 A0 IL 139064A0 IL 13906400 A IL13906400 A IL 13906400A IL 13906400 A IL13906400 A IL 13906400A IL 139064 A0 IL139064 A0 IL 139064A0
Authority
IL
Israel
Prior art keywords
intermittent claudication
bond
group
dotted line
hydrogen atom
Prior art date
Application number
IL13906400A
Other languages
English (en)
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of IL139064A0 publication Critical patent/IL139064A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13906400A 1999-02-17 2000-02-17 Intermittent claudication therapeutic drugs comprising pyrroloazepines IL139064A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3863199 1999-02-17
PCT/JP2000/000883 WO2000048602A1 (en) 1999-02-17 2000-02-17 Intermittent claudication therapeutic drugs comprising pyrroloazepines

Publications (1)

Publication Number Publication Date
IL139064A0 true IL139064A0 (en) 2001-11-25

Family

ID=12530599

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13906400A IL139064A0 (en) 1999-02-17 2000-02-17 Intermittent claudication therapeutic drugs comprising pyrroloazepines

Country Status (13)

Country Link
US (1) US6288056B1 (de)
EP (1) EP1071427B1 (de)
JP (1) JP2002537259A (de)
KR (1) KR20010042658A (de)
CN (1) CN1201740C (de)
AT (1) ATE269704T1 (de)
AU (1) AU2572400A (de)
CA (1) CA2329524A1 (de)
DE (1) DE60011711T2 (de)
ES (1) ES2220396T3 (de)
HU (1) HUP0105469A3 (de)
IL (1) IL139064A0 (de)
WO (1) WO2000048602A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11193290A (ja) * 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド系化合物
KR100677594B1 (ko) * 2005-06-10 2007-02-02 삼성전자주식회사 반도전성 벨트, 그 제조방법, 및 상기 반도전성 벨트를포함하는 전자사진 화상형성장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0525128A (ja) * 1990-05-11 1993-02-02 Suntory Ltd ピロロアゼピン誘導体の製造方法
IL121432A (en) * 1995-12-01 2000-09-28 Suntory Ltd Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE60011711T2 (de) 2005-07-07
US6288056B1 (en) 2001-09-11
JP2002537259A (ja) 2002-11-05
AU2572400A (en) 2000-09-04
ATE269704T1 (de) 2004-07-15
HUP0105469A3 (en) 2003-01-28
CA2329524A1 (en) 2000-08-24
CN1201740C (zh) 2005-05-18
WO2000048602A1 (en) 2000-08-24
EP1071427A1 (de) 2001-01-31
KR20010042658A (ko) 2001-05-25
ES2220396T3 (es) 2004-12-16
DE60011711D1 (de) 2004-07-29
HUP0105469A2 (hu) 2002-05-29
CN1297351A (zh) 2001-05-30
EP1071427B1 (de) 2004-06-23

Similar Documents

Publication Publication Date Title
EG25822A (en) Quinolinyl-pyrrolopyrazoles
GB9914486D0 (en) Medicaments
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
TNSN04185A1 (en) Combined use of antitumor indolopyrrolocarbazole derivative and other antitumor agent
MY121623A (en) Methods of preventing breast cancer.
PL342099A1 (en) Therapeutic agents
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
IL139064A0 (en) Intermittent claudication therapeutic drugs comprising pyrroloazepines
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
MXPA01012936A (es) Composicion farmaceutica que contiene sibutramina y orlistat.
SE0004462D0 (sv) Novel method and use
NO20014806L (no) Kombinasjonspreparat for behandling av malaria
AR023282A1 (es) Derivados de higromicina
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
YU30602A (sh) Primena 2-amino-3,4-dihidro-hinazolina za proizvodnju leka za lečenje ili profilaksu bolesti koje su prouzrokovane ishemičnim stanjima
IL124128A (en) Composition comprising a benzoylphenylurea for treatment of topical fungal infection
NZ513033A (en) Dry skin remedies
ATE397615T1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
NZ308024A (en) The reaction product of alkaloids of Chelidonium maius L. with thiophosphoric acid triaziridide is used as radiation treatment medicine
TR200102262T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.
NZ336321A (en) Use of benzothiophene (raloxifene) for treating breast cancer
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
NZ519747A (en) Quaternary ammonium and their use as anti-tussive agent
ECSP003744A (es) Derivados de higromicina